Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin

7. juli 2026 opdateret af: Rejuvaskin
This is a single-arm, open-label, decentralized (fully remote) clinical trial evaluating the tolerability and self-perceived skin effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in 35 adults aged 18-65 with self-reported eczema-prone skin. Participants will use the body wash once daily in place of their usual cleanser, followed by the Skin Recovery Cream, for 4 consecutive weeks.

Studieoversigt

Status

Aktiv, ikke rekrutterende

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

35

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89118
        • Citruslabs

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Adult women or men aged 18-65 years.
  • Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body).
  • Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment.
  • Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks.
  • Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks.
  • Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration.
  • Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone.
  • Able to read, understand, and complete questionnaires in English.
  • Resides in the United States with a valid shipping address.
  • Willing to provide informed consent and comply with all study procedures

Exclusion Criteria:

  • Known allergy or sensitivity to any ingredient in the study product.
  • Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites).
  • Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study.
  • Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Rejuvaskin Eczema Body Wash Arm
Kosttilskud: Rejuvaskin Eczema Body Wash
Participants use Rejuvaskin Eczema Body Wash once daily during a shower or bath in place of their usual body cleanser, followed by application of Rejuvaskin Skin Recovery Cream, for 4 consecutive weeks.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from Baseline in Self-Reported Skin Dryness
Tidsramme: Baseline to Week 4
Mean change in self-reported dryness measured via a structured self-report questionnaire administered through the Citruslabs platform
Baseline to Week 4
Change from Baseline in Self-Reported Skin Roughness
Tidsramme: Baseline to Week 4
Mean change in self-reported roughness measured via a structured self-report questionnaire administered through the Citruslabs platform
Baseline to Week 4
Change from Baseline in Self-Reported Skin Itch
Tidsramme: Baseline to Week 4
Mean change in self-reported itch measured via a structured self-report questionnaire administered through the Citruslabs platform
Baseline to Week 4
Change from Baseline in Self-Reported Skin Irritation
Tidsramme: Baseline to Week 4
Mean change in self-reported irritation measured via a structured self-report questionnaire administered through the Citruslabs platform
Baseline to Week 4
Change from Baseline in Self-Reported Skin Discomfort
Tidsramme: Baseline to Week 4
Mean change in self-reported discomfort measured via a structured self-report questionnaire administered through the Citruslabs platform
Baseline to Week 4

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from Baseline in Self-Reported Skin Hydration
Tidsramme: Baseline to Week 4
Mean change in self-reported skin hydration measured via a 0-10 Numeric Rating Scale (NRS) self-report questionnaire
Baseline to Week 4
Change from Baseline in Self-Reported Skin Comfort
Tidsramme: Baseline to Week 4
Mean change in self-reported skin hydration measured via a 0-10 Numeric Rating Scale (NRS) self-report questionnaire
Baseline to Week 4
Expert Dermatologist-Graded Change in Erythema
Tidsramme: Baseline and Week 4
Independent expert dermatologist grading of change in erythema from standardized photographs of a designated affected body area
Baseline and Week 4
Expert Dermatologist-Graded Change in Scaling
Tidsramme: Baseline and Week 4
Independent expert dermatologist grading of change in scaling from standardized photographs of a designated affected body area
Baseline and Week 4

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Rejuvaskin

Samarbejdspartnere

Citruslabs

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

6. juli 2026

Primær færdiggørelse (Anslået)

1. august 2026

Studieafslutning (Anslået)

1. august 2026

Datoer for studieregistrering

Først indsendt

7. juli 2026

Først indsendt, der opfyldte QC-kriterier

7. juli 2026

Først opslået (Faktiske)

14. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

14. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

7. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • REJUV-40748

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Rejuvaskin Eczema Body Wash

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Bulgaria

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner